Overview This page contains the latest trade data of Streptomycins, derivatives, in bulk, salts. In 2022, Streptomycins, derivatives, in bulk, salts were the world's 4265th most traded product, with a total trade of $68.7M. Between 2021 and 2022 the exports of Streptomycins, derivatives, in bulk, salts decreased by -6.08%, from $73.1M to $68.7M. Trade in Streptomycins, derivatives, in bulk, salts represent 0.00029% of total world trade.
Streptomycins, derivatives, in bulk, salts are a part of Antibiotics.
Exports In 2022 the top exporters of Streptomycins, derivatives, in bulk, salts were China ($47.2M), Netherlands ($6.83M), United States ($5.42M), South Korea ($2.45M), and Germany ($1.2M).
Imports In 2022 the top importers of Streptomycins, derivatives, in bulk, salts were Netherlands ($8.27M), India ($6.51M), Belgium ($4.04M), Egypt ($3.46M), and France ($3.42M).
Ranking Streptomycins, derivatives, in bulk, salts ranks 265th in the Product Complexity Index (PCI).
Description Streptomycins are a group of antibiotic drugs that are used to kill bacteria. Streptomycins bind to the ribosomes of bacteria and inhibit protein synthesis. Streptomycin is also used to treat tuberculosis. Streptomycin derivatives, such as amikacin, gentamicin, kanamycin, neomycin, and tobramycin, are antibiotics that are used to treat various bacterial infections. Streptomycin salts are derivatives of streptomycin and are used to treat tuberculosis.